Data sourcesSEC Form 415m ago
House PTR15m ago
SEC 13F15m ago
Robinhood Chain15m ago
Public companyEyePoint, Inc.
EYPTCIK 0001314102
Price$0.36
1 year-96.7%
Disclosed transactions26
Buys / sells0 / 7
Max Insider Score20
Connections with evidence5
EYPT · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | — 2,438 sh | Jun 30, 2026 | Jul 2, 2026 |
| 9 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 2,437 sh | Jun 30, 2026 | Jul 2, 2026 traded Jun 30, 2026 | +2d | SEC Form 4 | |
| 13 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 2,438 sh | Jun 30, 2026 | Jul 2, 2026 traded Jun 30, 2026 | +2d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | $20K 2,437 sh | Jun 30, 2026 | Jul 2, 2026 traded Jun 30, 2026 | +2d | SEC Form 4 | |
| 7 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | $20K 2,438 sh | Jun 30, 2026 | Jul 2, 2026 traded Jun 30, 2026 | +2d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | — 2,437 sh | Jun 30, 2026 | Jul 2, 2026 traded Jun 30, 2026 | +2d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | $20K 2,437 sh | Apr 17, 2026 | Apr 20, 2026 traded Apr 17, 2026 | +3d | SEC Form 4 | |
| 13 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 2,437 sh | Apr 17, 2026 | Apr 20, 2026 traded Apr 17, 2026 | +3d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | — 2,437 sh | Apr 17, 2026 | Apr 20, 2026 traded Apr 17, 2026 | +3d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | — 2,438 sh | Mar 4, 2026 | Mar 5, 2026 traded Mar 4, 2026 | +1d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | $20K 2,438 sh | Mar 4, 2026 | Mar 5, 2026 traded Mar 4, 2026 | +1d | SEC Form 4 | |
| 13 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 2,438 sh | Mar 4, 2026 | Mar 5, 2026 traded Mar 4, 2026 | +1d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | $20K 2,437 sh | Feb 17, 2026 | Feb 18, 2026 traded Feb 17, 2026 | +1d | SEC Form 4 | |
| 0 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | — 2,437 sh | Feb 17, 2026 | Feb 18, 2026 traded Feb 17, 2026 | +1d | SEC Form 4 | |
| 13 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 2,437 sh | Feb 17, 2026 | Feb 18, 2026 traded Feb 17, 2026 | +1d | SEC Form 4 | |
| 7 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | — 29.3K sh | Jan 5, 2026 | Jan 7, 2026 traded Jan 5, 2026 | +2d | SEC Form 4 | |
| 19 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $727K 42.5K sh | Jan 5, 2026 | Jan 7, 2026 traded Jan 5, 2026 | +2d | SEC Form 4 | |
| 10 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | $242K 29.3K sh | Jan 5, 2026 | Jan 7, 2026 traded Jan 5, 2026 | +2d | SEC Form 4 | |
| 9 | SJSanders Reginald J.Director | EYPTEyePoint, Inc. Grant or award | A | — 40.0K sh | Jan 2, 2026 | Jan 6, 2026 traded Jan 2, 2026 | +4d | SEC Form 4 | |
| 5 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Grant or award | A | — 171.4K sh | Jan 2, 2026 | Jan 6, 2026 traded Jan 2, 2026 | +4d | SEC Form 4 | |
| 5 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Grant or award | A | — 85.7K sh | Jan 2, 2026 | Jan 6, 2026 traded Jan 2, 2026 | +4d | SEC Form 4 | |
| 5 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise | M | — 19.7K sh | Jan 3, 2026 | Jan 6, 2026 traded Jan 3, 2026 | +3d | SEC Form 4 | |
| 17 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise | M | — 19.7K sh | Jan 3, 2026 | Jan 6, 2026 traded Jan 3, 2026 | +3d | SEC Form 4 | |
| 20 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Tax withholding | F | $111K 6,373 sh | Jan 3, 2026 | Jan 6, 2026 traded Jan 3, 2026 | +3d | SEC Form 4 | |
| 9 | | EYPTEyePoint, Inc. Grant or award | A | — 40.0K sh | Jan 2, 2026 | Jan 6, 2026 traded Jan 2, 2026 | +4d | SEC Form 4 | |
| 17 | RRRibeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 2,722 sh | Nov 11, 2025 | Nov 12, 2025 traded Nov 11, 2025 | +1d | SEC Form 4 | |
Chief Medical Officer · Nov 12, 2025
Planned sales and 5% stakes
Form 144, 13D and 13G